查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1857132

纤维蛋白原：2025-2031年全球市占率排名、总销售额与需求预测

Fibrinogen - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
出版日期: | 出版商: QYResearch | 英文 100 Pages | 商品交期: 2-3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2024年全球纤维蛋白原市场规模估计为12.57亿美元，预计到2031年将达到25.25亿美元，在2025-2031年的预测期内，复合年增长率为10.3%。

本报告对纤维蛋白原的跨境产业布局、资本配置模式、区域经济相互依存关係以及近期关税调整和国际供应链重组战略措施进行了全面评估。

纤维蛋白原（因子I）是一种脊椎动物糖蛋白，有助于血液凝固。纤维蛋白原浓缩物用于治疗血液疾病。纤维蛋白原浓缩物是由混合血浆製备的凝血因子製剂。目前，只有RiaStap（CSL Behring公司）在许多国家获得许可，可用于多种适应症，包括治疗与低纤维蛋白原血症相关的急性出血。其他製造商的产品仅在其各自的地区或​​国家/地区销售。

纤维蛋白原市场的主要驱动力是出血性疾病和需要快速止血的外科手术的日益增多，以及人们对标靶血液管理疗法的认识和应用不断提高。血浆分馏和重组技术的进步，以及对更安全、无病原体和高纯度血液製品的需求不断增长，也推动了市场成长。此外，人口老化、创伤和心血管手术发生率的上升，以及新兴地区医疗基础设施的持续改善，也促进了对纤维蛋白原浓缩物的需求成长。

全球主要的纤维蛋白原浓缩物生产商包括CSL Behring、LFB集团和上海瑞安血液製品有限公司。市占率最大的公司约为52%。北美市占率最大，约31%，其次是欧洲（约28%）和亚太地区（约26%）。

本报告旨在全面概述全球纤维蛋白原市场，重点关注总销售量、收入、价格、市场份额和主要企业的排名，并按地区、国家、类型和应用进行分析。

本报告以销售量（公斤）和销售收入（百万美元）为单位，提供纤维蛋白原市场规模、估算和预测数据，涵盖2020年至2031年的历史数据和预测数据，并以2024年为基准年。定量和定性分析将帮助读者制定业务/成长策略、评估市场竞争格局、分析公司在当前市场中的地位，并就纤维蛋白原业务做出明智的决策。

目录

第一章 市场概览

  • 纤维蛋白原产品介绍
  • 全球纤维蛋白原市场规模预测
  • 纤维蛋白原市场趋势及驱动因素
  • 前提条件和限制条件
  • 调查目的
  • 多年的考虑

第二章 公司竞争分析

  • 全球纤维蛋白原公司营收排名（2024 年）
  • 全球纤维蛋白原公司营收（2020-2025 年）
  • 全球纤维蛋白原销售量排名（2024 年）
  • 全球各公司纤维蛋白原销售量（2020-2025 年）
  • 全球纤维蛋白原平均价格（按公司划分）（2020-2025 年）
  • 纤维蛋白原製造地分布及主要生产商总部所在地
  • 主要製造商提供的纤维蛋白原产品
  • 大型生产商何时开始大规模生产纤维蛋白原？
  • 纤维蛋白原市场竞争分析
  • 併购、扩张

第三章 依类型细分

  • 按类型介绍
    • 人类纤维蛋白原
    • 动物纤维蛋白原
  • 全球纤维蛋白原销售额（按类型划分）
  • 全球纤维蛋白原销售量（按类型划分）
  • 全球纤维蛋白原平均价格（按类型划分）（2020-2031 年）

第四章 按应用进行细分

  • 透过申请
    • 先天性纤维蛋白原缺乏症
    • 手术过程
    • 其他的
  • 全球纤维蛋白原销售额（以使用量计）
  • 全球纤维蛋白原销售量）
  • 全球纤维蛋白原平均价格（按用途划分）（2020-2031 年）

第五章 区域细分

  • 全球纤维蛋白原销售额（按地区划分）
  • 全球纤维蛋白原销售量（按地区划分）
  • 全球各地区纤维蛋白原平均价格（2020-2031 年）
  • 北美洲
  • 欧洲
  • 亚太地区
  • 南美洲
  • 中东和非洲

第六章 按主要国家划分

  • 主要国家和地区纤维蛋白原销售额成长趋势（2020 年、2024 年和 2031 年比较）
  • 主要国家和地区的纤维蛋白原销售额和销售量
  • 美国
  • 欧洲
  • 中国
  • 日本
  • 韩国
  • 东南亚
  • 印度

第七章 公司简介

  • CSL Behring
  • LFB Group
  • Shanghai RAAS Blood Products
  • China Resources Boya Bio-pharmaceutical
  • Hualan Biological Engineering
  • Harbin Pacific Biopharmaceutical
  • China Meheco Group
  • Taibang Biologic
  • Octapharma

第八章：产业链分析

第九章 研究结果与结论

第十章附录

The global market for Fibrinogen was estimated to be worth US$ 1257 million in 2024 and is forecast to a readjusted size of US$ 2525 million by 2031 with a CAGR of 10.3% during the forecast period 2025-2031.

This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Fibrinogen cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.

Fibrinogen (factor I) is a glycoprotein in vertebrates that helps in the formation of blood clots. Fibrinogen Concentrate is used as a medicine for blood disease. Fibrinogen concentrate is a preparation of coagulation factors prepared from pooled plasma. Currently, only RiaSTAP (CSL Behring) is licensed in a number of countries for multiple indications including treating acute bleeding episodes with Hypofibrinogenemia. Other manufacturer's products are justly used in local region or countries.

The market for fibrinogen is primarily driven by the increasing prevalence of bleeding disorders and surgical procedures that require rapid hemostasis, as well as growing awareness and adoption of targeted blood management therapies. Advances in plasma fractionation and recombinant technologies, along with rising demand for safer, pathogen-reduced, and high-purity blood products, are also fueling market growth. Additionally, an aging population, higher incidence of trauma and cardiovascular surgeries, and expansion of healthcare infrastructure in emerging regions contribute to the increasing demand for fibrinogen concentrate.

Global core fibrinogen manufacturers include CSL Behring, LFB Group and Shanghai RAAS Blood Products etc. The top 1 companies hold a share about 52%. North America is the largest market, with a share about 31%, followed by Europe and Asia Pacific with the share about 28% and 26%.

This report aims to provide a comprehensive presentation of the global market for Fibrinogen, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Fibrinogen by region & country, by Type, and by Application.

The Fibrinogen market size, estimations, and forecasts are provided in terms of sales volume (Kg) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Fibrinogen.

Market Segmentation

By Company

  • CSL Behring
  • LFB Group
  • Shanghai RAAS Blood Products
  • China Resources Boya Bio-pharmaceutical
  • Hualan Biological Engineering
  • Harbin Pacific Biopharmaceutical
  • China Meheco Group
  • Taibang Biologic
  • Octapharma

Segment by Type

  • Human Fibrinogen
  • Animal Fibrinogen

Segment by Application

  • Congenital Fibrinogen Deficiency
  • Surgical Procedures
  • Others

By Region

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Netherlands
    • Nordic Countries
    • Rest of Europe
  • Latin America
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • UAE
    • Rest of MEA

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Fibrinogen manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Sales, revenue of Fibrinogen in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Sales, revenue of Fibrinogen in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

Table of Contents

1 Market Overview

  • 1.1 Fibrinogen Product Introduction
  • 1.2 Global Fibrinogen Market Size Forecast
    • 1.2.1 Global Fibrinogen Sales Value (2020-2031)
    • 1.2.2 Global Fibrinogen Sales Volume (2020-2031)
    • 1.2.3 Global Fibrinogen Sales Price (2020-2031)
  • 1.3 Fibrinogen Market Trends & Drivers
    • 1.3.1 Fibrinogen Industry Trends
    • 1.3.2 Fibrinogen Market Drivers & Opportunity
    • 1.3.3 Fibrinogen Market Challenges
    • 1.3.4 Fibrinogen Market Restraints
  • 1.4 Assumptions and Limitations
  • 1.5 Study Objectives
  • 1.6 Years Considered

2 Competitive Analysis by Company

  • 2.1 Global Fibrinogen Players Revenue Ranking (2024)
  • 2.2 Global Fibrinogen Revenue by Company (2020-2025)
  • 2.3 Global Fibrinogen Players Sales Volume Ranking (2024)
  • 2.4 Global Fibrinogen Sales Volume by Company Players (2020-2025)
  • 2.5 Global Fibrinogen Average Price by Company (2020-2025)
  • 2.6 Key Manufacturers Fibrinogen Manufacturing Base and Headquarters
  • 2.7 Key Manufacturers Fibrinogen Product Offered
  • 2.8 Key Manufacturers Time to Begin Mass Production of Fibrinogen
  • 2.9 Fibrinogen Market Competitive Analysis
    • 2.9.1 Fibrinogen Market Concentration Rate (2020-2025)
    • 2.9.2 Global 5 and 10 Largest Manufacturers by Fibrinogen Revenue in 2024
    • 2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Fibrinogen as of 2024)
  • 2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

  • 3.1 Introduction by Type
    • 3.1.1 Human Fibrinogen
    • 3.1.2 Animal Fibrinogen
  • 3.2 Global Fibrinogen Sales Value by Type
    • 3.2.1 Global Fibrinogen Sales Value by Type (2020 VS 2024 VS 2031)
    • 3.2.2 Global Fibrinogen Sales Value, by Type (2020-2031)
    • 3.2.3 Global Fibrinogen Sales Value, by Type (%) (2020-2031)
  • 3.3 Global Fibrinogen Sales Volume by Type
    • 3.3.1 Global Fibrinogen Sales Volume by Type (2020 VS 2024 VS 2031)
    • 3.3.2 Global Fibrinogen Sales Volume, by Type (2020-2031)
    • 3.3.3 Global Fibrinogen Sales Volume, by Type (%) (2020-2031)
  • 3.4 Global Fibrinogen Average Price by Type (2020-2031)

4 Segmentation by Application

  • 4.1 Introduction by Application
    • 4.1.1 Congenital Fibrinogen Deficiency
    • 4.1.2 Surgical Procedures
    • 4.1.3 Others
  • 4.2 Global Fibrinogen Sales Value by Application
    • 4.2.1 Global Fibrinogen Sales Value by Application (2020 VS 2024 VS 2031)
    • 4.2.2 Global Fibrinogen Sales Value, by Application (2020-2031)
    • 4.2.3 Global Fibrinogen Sales Value, by Application (%) (2020-2031)
  • 4.3 Global Fibrinogen Sales Volume by Application
    • 4.3.1 Global Fibrinogen Sales Volume by Application (2020 VS 2024 VS 2031)
    • 4.3.2 Global Fibrinogen Sales Volume, by Application (2020-2031)
    • 4.3.3 Global Fibrinogen Sales Volume, by Application (%) (2020-2031)
  • 4.4 Global Fibrinogen Average Price by Application (2020-2031)

5 Segmentation by Region

  • 5.1 Global Fibrinogen Sales Value by Region
    • 5.1.1 Global Fibrinogen Sales Value by Region: 2020 VS 2024 VS 2031
    • 5.1.2 Global Fibrinogen Sales Value by Region (2020-2025)
    • 5.1.3 Global Fibrinogen Sales Value by Region (2026-2031)
    • 5.1.4 Global Fibrinogen Sales Value by Region (%), (2020-2031)
  • 5.2 Global Fibrinogen Sales Volume by Region
    • 5.2.1 Global Fibrinogen Sales Volume by Region: 2020 VS 2024 VS 2031
    • 5.2.2 Global Fibrinogen Sales Volume by Region (2020-2025)
    • 5.2.3 Global Fibrinogen Sales Volume by Region (2026-2031)
    • 5.2.4 Global Fibrinogen Sales Volume by Region (%), (2020-2031)
  • 5.3 Global Fibrinogen Average Price by Region (2020-2031)
  • 5.4 North America
    • 5.4.1 North America Fibrinogen Sales Value, 2020-2031
    • 5.4.2 North America Fibrinogen Sales Value by Country (%), 2024 VS 2031
  • 5.5 Europe
    • 5.5.1 Europe Fibrinogen Sales Value, 2020-2031
    • 5.5.2 Europe Fibrinogen Sales Value by Country (%), 2024 VS 2031
  • 5.6 Asia Pacific
    • 5.6.1 Asia Pacific Fibrinogen Sales Value, 2020-2031
    • 5.6.2 Asia Pacific Fibrinogen Sales Value by Region (%), 2024 VS 2031
  • 5.7 South America
    • 5.7.1 South America Fibrinogen Sales Value, 2020-2031
    • 5.7.2 South America Fibrinogen Sales Value by Country (%), 2024 VS 2031
  • 5.8 Middle East & Africa
    • 5.8.1 Middle East & Africa Fibrinogen Sales Value, 2020-2031
    • 5.8.2 Middle East & Africa Fibrinogen Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

  • 6.1 Key Countries/Regions Fibrinogen Sales Value Growth Trends, 2020 VS 2024 VS 2031
  • 6.2 Key Countries/Regions Fibrinogen Sales Value and Sales Volume
    • 6.2.1 Key Countries/Regions Fibrinogen Sales Value, 2020-2031
    • 6.2.2 Key Countries/Regions Fibrinogen Sales Volume, 2020-2031
  • 6.3 United States
    • 6.3.1 United States Fibrinogen Sales Value, 2020-2031
    • 6.3.2 United States Fibrinogen Sales Value by Type (%), 2024 VS 2031
    • 6.3.3 United States Fibrinogen Sales Value by Application, 2024 VS 2031
  • 6.4 Europe
    • 6.4.1 Europe Fibrinogen Sales Value, 2020-2031
    • 6.4.2 Europe Fibrinogen Sales Value by Type (%), 2024 VS 2031
    • 6.4.3 Europe Fibrinogen Sales Value by Application, 2024 VS 2031
  • 6.5 China
    • 6.5.1 China Fibrinogen Sales Value, 2020-2031
    • 6.5.2 China Fibrinogen Sales Value by Type (%), 2024 VS 2031
    • 6.5.3 China Fibrinogen Sales Value by Application, 2024 VS 2031
  • 6.6 Japan
    • 6.6.1 Japan Fibrinogen Sales Value, 2020-2031
    • 6.6.2 Japan Fibrinogen Sales Value by Type (%), 2024 VS 2031
    • 6.6.3 Japan Fibrinogen Sales Value by Application, 2024 VS 2031
  • 6.7 South Korea
    • 6.7.1 South Korea Fibrinogen Sales Value, 2020-2031
    • 6.7.2 South Korea Fibrinogen Sales Value by Type (%), 2024 VS 2031
    • 6.7.3 South Korea Fibrinogen Sales Value by Application, 2024 VS 2031
  • 6.8 Southeast Asia
    • 6.8.1 Southeast Asia Fibrinogen Sales Value, 2020-2031
    • 6.8.2 Southeast Asia Fibrinogen Sales Value by Type (%), 2024 VS 2031
    • 6.8.3 Southeast Asia Fibrinogen Sales Value by Application, 2024 VS 2031
  • 6.9 India
    • 6.9.1 India Fibrinogen Sales Value, 2020-2031
    • 6.9.2 India Fibrinogen Sales Value by Type (%), 2024 VS 2031
    • 6.9.3 India Fibrinogen Sales Value by Application, 2024 VS 2031

7 Company Profiles

  • 7.1 CSL Behring
    • 7.1.1 CSL Behring Company Information
    • 7.1.2 CSL Behring Introduction and Business Overview
    • 7.1.3 CSL Behring Fibrinogen Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.1.4 CSL Behring Fibrinogen Product Offerings
    • 7.1.5 CSL Behring Recent Development
  • 7.2 LFB Group
    • 7.2.1 LFB Group Company Information
    • 7.2.2 LFB Group Introduction and Business Overview
    • 7.2.3 LFB Group Fibrinogen Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.2.4 LFB Group Fibrinogen Product Offerings
    • 7.2.5 LFB Group Recent Development
  • 7.3 Shanghai RAAS Blood Products
    • 7.3.1 Shanghai RAAS Blood Products Company Information
    • 7.3.2 Shanghai RAAS Blood Products Introduction and Business Overview
    • 7.3.3 Shanghai RAAS Blood Products Fibrinogen Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.3.4 Shanghai RAAS Blood Products Fibrinogen Product Offerings
    • 7.3.5 Shanghai RAAS Blood Products Recent Development
  • 7.4 China Resources Boya Bio-pharmaceutical
    • 7.4.1 China Resources Boya Bio-pharmaceutical Company Information
    • 7.4.2 China Resources Boya Bio-pharmaceutical Introduction and Business Overview
    • 7.4.3 China Resources Boya Bio-pharmaceutical Fibrinogen Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.4.4 China Resources Boya Bio-pharmaceutical Fibrinogen Product Offerings
    • 7.4.5 China Resources Boya Bio-pharmaceutical Recent Development
  • 7.5 Hualan Biological Engineering
    • 7.5.1 Hualan Biological Engineering Company Information
    • 7.5.2 Hualan Biological Engineering Introduction and Business Overview
    • 7.5.3 Hualan Biological Engineering Fibrinogen Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.5.4 Hualan Biological Engineering Fibrinogen Product Offerings
    • 7.5.5 Hualan Biological Engineering Recent Development
  • 7.6 Harbin Pacific Biopharmaceutical
    • 7.6.1 Harbin Pacific Biopharmaceutical Company Information
    • 7.6.2 Harbin Pacific Biopharmaceutical Introduction and Business Overview
    • 7.6.3 Harbin Pacific Biopharmaceutical Fibrinogen Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.6.4 Harbin Pacific Biopharmaceutical Fibrinogen Product Offerings
    • 7.6.5 Harbin Pacific Biopharmaceutical Recent Development
  • 7.7 China Meheco Group
    • 7.7.1 China Meheco Group Company Information
    • 7.7.2 China Meheco Group Introduction and Business Overview
    • 7.7.3 China Meheco Group Fibrinogen Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.7.4 China Meheco Group Fibrinogen Product Offerings
    • 7.7.5 China Meheco Group Recent Development
  • 7.8 Taibang Biologic
    • 7.8.1 Taibang Biologic Company Information
    • 7.8.2 Taibang Biologic Introduction and Business Overview
    • 7.8.3 Taibang Biologic Fibrinogen Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.8.4 Taibang Biologic Fibrinogen Product Offerings
    • 7.8.5 Taibang Biologic Recent Development
  • 7.9 Octapharma
    • 7.9.1 Octapharma Company Information
    • 7.9.2 Octapharma Introduction and Business Overview
    • 7.9.3 Octapharma Fibrinogen Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.9.4 Octapharma Fibrinogen Product Offerings
    • 7.9.5 Octapharma Recent Development

8 Industry Chain Analysis

  • 8.1 Fibrinogen Industrial Chain
  • 8.2 Fibrinogen Upstream Analysis
    • 8.2.1 Key Raw Materials
    • 8.2.2 Raw Materials Key Suppliers
    • 8.2.3 Manufacturing Cost Structure
  • 8.3 Midstream Analysis
  • 8.4 Downstream Analysis (Customers Analysis)
  • 8.5 Sales Model and Sales Channels
    • 8.5.1 Fibrinogen Sales Model
    • 8.5.2 Sales Channel
    • 8.5.3 Fibrinogen Distributors

9 Research Findings and Conclusion

10 Appendix

  • 10.1 Research Methodology
    • 10.1.1 Methodology/Research Approach
      • 10.1.1.1 Research Programs/Design
      • 10.1.1.2 Market Size Estimation
      • 10.1.1.3 Market Breakdown and Data Triangulation
    • 10.1.2 Data Source
      • 10.1.2.1 Secondary Sources
      • 10.1.2.2 Primary Sources
  • 10.2 Author Details
  • 10.3 Disclaimer

List of Tables

  • Table 1. Fibrinogen Market Trends
  • Table 2. Fibrinogen Market Drivers & Opportunity
  • Table 3. Fibrinogen Market Challenges
  • Table 4. Fibrinogen Market Restraints
  • Table 5. Global Fibrinogen Revenue by Company (2020-2025) & (US$ Million)
  • Table 6. Global Fibrinogen Revenue Market Share by Company (2020-2025)
  • Table 7. Global Fibrinogen Sales Volume by Company (2020-2025) & (Kg)
  • Table 8. Global Fibrinogen Sales Volume Market Share by Company (2020-2025)
  • Table 9. Global Market Fibrinogen Price by Company (2020-2025) & (US$/g)
  • Table 10. Key Manufacturers Fibrinogen Manufacturing Base and Headquarters
  • Table 11. Key Manufacturers Fibrinogen Product Type
  • Table 12. Key Manufacturers Time to Begin Mass Production of Fibrinogen
  • Table 13. Global Fibrinogen Manufacturers Market Concentration Ratio (CR5 and HHI)
  • Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Fibrinogen as of 2024)
  • Table 15. Mergers & Acquisitions, Expansion Plans
  • Table 16. Global Fibrinogen Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
  • Table 17. Global Fibrinogen Sales Value by Type (2020-2025) & (US$ Million)
  • Table 18. Global Fibrinogen Sales Value by Type (2026-2031) & (US$ Million)
  • Table 19. Global Fibrinogen Sales Market Share in Value by Type (2020-2025)
  • Table 20. Global Fibrinogen Sales Market Share in Value by Type (2026-2031)
  • Table 21. Global Fibrinogen Sales Volume by Type: 2020 VS 2024 VS 2031 (Kg)
  • Table 22. Global Fibrinogen Sales Volume by Type (2020-2025) & (Kg)
  • Table 23. Global Fibrinogen Sales Volume by Type (2026-2031) & (Kg)
  • Table 24. Global Fibrinogen Sales Market Share in Volume by Type (2020-2025)
  • Table 25. Global Fibrinogen Sales Market Share in Volume by Type (2026-2031)
  • Table 26. Global Fibrinogen Price by Type (2020-2025) & (US$/g)
  • Table 27. Global Fibrinogen Price by Type (2026-2031) & (US$/g)
  • Table 28. Global Fibrinogen Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
  • Table 29. Global Fibrinogen Sales Value by Application (2020-2025) & (US$ Million)
  • Table 30. Global Fibrinogen Sales Value by Application (2026-2031) & (US$ Million)
  • Table 31. Global Fibrinogen Sales Market Share in Value by Application (2020-2025)
  • Table 32. Global Fibrinogen Sales Market Share in Value by Application (2026-2031)
  • Table 33. Global Fibrinogen Sales Volume by Application: 2020 VS 2024 VS 2031 (Kg)
  • Table 34. Global Fibrinogen Sales Volume by Application (2020-2025) & (Kg)
  • Table 35. Global Fibrinogen Sales Volume by Application (2026-2031) & (Kg)
  • Table 36. Global Fibrinogen Sales Market Share in Volume by Application (2020-2025)
  • Table 37. Global Fibrinogen Sales Market Share in Volume by Application (2026-2031)
  • Table 38. Global Fibrinogen Price by Application (2020-2025) & (US$/g)
  • Table 39. Global Fibrinogen Price by Application (2026-2031) & (US$/g)
  • Table 40. Global Fibrinogen Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
  • Table 41. Global Fibrinogen Sales Value by Region (2020-2025) & (US$ Million)
  • Table 42. Global Fibrinogen Sales Value by Region (2026-2031) & (US$ Million)
  • Table 43. Global Fibrinogen Sales Value by Region (2020-2025) & (%)
  • Table 44. Global Fibrinogen Sales Value by Region (2026-2031) & (%)
  • Table 45. Global Fibrinogen Sales Volume by Region (Kg): 2020 VS 2024 VS 2031
  • Table 46. Global Fibrinogen Sales Volume by Region (2020-2025) & (Kg)
  • Table 47. Global Fibrinogen Sales Volume by Region (2026-2031) & (Kg)
  • Table 48. Global Fibrinogen Sales Volume by Region (2020-2025) & (%)
  • Table 49. Global Fibrinogen Sales Volume by Region (2026-2031) & (%)
  • Table 50. Global Fibrinogen Average Price by Region (2020-2025) & (US$/g)
  • Table 51. Global Fibrinogen Average Price by Region (2026-2031) & (US$/g)
  • Table 52. Key Countries/Regions Fibrinogen Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
  • Table 53. Key Countries/Regions Fibrinogen Sales Value, (2020-2025) & (US$ Million)
  • Table 54. Key Countries/Regions Fibrinogen Sales Value, (2026-2031) & (US$ Million)
  • Table 55. Key Countries/Regions Fibrinogen Sales Volume, (2020-2025) & (Kg)
  • Table 56. Key Countries/Regions Fibrinogen Sales Volume, (2026-2031) & (Kg)
  • Table 57. CSL Behring Company Information
  • Table 58. CSL Behring Introduction and Business Overview
  • Table 59. CSL Behring Fibrinogen Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
  • Table 60. CSL Behring Fibrinogen Product Offerings
  • Table 61. CSL Behring Recent Development
  • Table 62. LFB Group Company Information
  • Table 63. LFB Group Introduction and Business Overview
  • Table 64. LFB Group Fibrinogen Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
  • Table 65. LFB Group Fibrinogen Product Offerings
  • Table 66. LFB Group Recent Development
  • Table 67. Shanghai RAAS Blood Products Company Information
  • Table 68. Shanghai RAAS Blood Products Introduction and Business Overview
  • Table 69. Shanghai RAAS Blood Products Fibrinogen Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
  • Table 70. Shanghai RAAS Blood Products Fibrinogen Product Offerings
  • Table 71. Shanghai RAAS Blood Products Recent Development
  • Table 72. China Resources Boya Bio-pharmaceutical Company Information
  • Table 73. China Resources Boya Bio-pharmaceutical Introduction and Business Overview
  • Table 74. China Resources Boya Bio-pharmaceutical Fibrinogen Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
  • Table 75. China Resources Boya Bio-pharmaceutical Fibrinogen Product Offerings
  • Table 76. China Resources Boya Bio-pharmaceutical Recent Development
  • Table 77. Hualan Biological Engineering Company Information
  • Table 78. Hualan Biological Engineering Introduction and Business Overview
  • Table 79. Hualan Biological Engineering Fibrinogen Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
  • Table 80. Hualan Biological Engineering Fibrinogen Product Offerings
  • Table 81. Hualan Biological Engineering Recent Development
  • Table 82. Harbin Pacific Biopharmaceutical Company Information
  • Table 83. Harbin Pacific Biopharmaceutical Introduction and Business Overview
  • Table 84. Harbin Pacific Biopharmaceutical Fibrinogen Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
  • Table 85. Harbin Pacific Biopharmaceutical Fibrinogen Product Offerings
  • Table 86. Harbin Pacific Biopharmaceutical Recent Development
  • Table 87. China Meheco Group Company Information
  • Table 88. China Meheco Group Introduction and Business Overview
  • Table 89. China Meheco Group Fibrinogen Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
  • Table 90. China Meheco Group Fibrinogen Product Offerings
  • Table 91. China Meheco Group Recent Development
  • Table 92. Taibang Biologic Company Information
  • Table 93. Taibang Biologic Introduction and Business Overview
  • Table 94. Taibang Biologic Fibrinogen Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
  • Table 95. Taibang Biologic Fibrinogen Product Offerings
  • Table 96. Taibang Biologic Recent Development
  • Table 97. Octapharma Company Information
  • Table 98. Octapharma Introduction and Business Overview
  • Table 99. Octapharma Fibrinogen Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
  • Table 100. Octapharma Fibrinogen Product Offerings
  • Table 101. Octapharma Recent Development
  • Table 102. Key Raw Materials Lists
  • Table 103. Raw Materials Key Suppliers Lists
  • Table 104. Fibrinogen Downstream Customers
  • Table 105. Fibrinogen Distributors List
  • Table 106. Research Programs/Design for This Report
  • Table 107. Key Data Information from Secondary Sources
  • Table 108. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Fibrinogen Product Picture
  • Figure 2. Global Fibrinogen Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
  • Figure 3. Global Fibrinogen Sales Value (2020-2031) & (US$ Million)
  • Figure 4. Global Fibrinogen Sales Volume (2020-2031) & (Kg)
  • Figure 5. Global Fibrinogen Sales Price (2020-2031) & (US$/g)
  • Figure 6. Fibrinogen Report Years Considered
  • Figure 7. Global Fibrinogen Players Revenue Ranking (2024) & (US$ Million)
  • Figure 8. Global Fibrinogen Players Sales Volume Ranking (2024) & (Kg)
  • Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Fibrinogen Revenue in 2024
  • Figure 10. Fibrinogen Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
  • Figure 11. Human Fibrinogen Picture
  • Figure 12. Animal Fibrinogen Picture
  • Figure 13. Global Fibrinogen Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
  • Figure 14. Global Fibrinogen Sales Value Market Share by Type, 2024 & 2031
  • Figure 15. Global Fibrinogen Sales Volume by Type (2020 VS 2024 VS 2031) & (Kg)
  • Figure 16. Global Fibrinogen Sales Volume Market Share by Type, 2024 & 2031
  • Figure 17. Global Fibrinogen Price by Type (2020-2031) & (US$/g)
  • Figure 18. Product Picture of Congenital Fibrinogen Deficiency
  • Figure 19. Product Picture of Surgical Procedures
  • Figure 20. Product Picture of Others
  • Figure 21. Global Fibrinogen Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
  • Figure 22. Global Fibrinogen Sales Value Market Share by Application, 2024 & 2031
  • Figure 23. Global Fibrinogen Sales Volume by Application (2020 VS 2024 VS 2031) & (Kg)
  • Figure 24. Global Fibrinogen Sales Volume Market Share by Application, 2024 & 2031
  • Figure 25. Global Fibrinogen Price by Application (2020-2031) & (US$/g)
  • Figure 26. North America Fibrinogen Sales Value (2020-2031) & (US$ Million)
  • Figure 27. North America Fibrinogen Sales Value by Country (%), 2024 VS 2031
  • Figure 28. Europe Fibrinogen Sales Value, (2020-2031) & (US$ Million)
  • Figure 29. Europe Fibrinogen Sales Value by Country (%), 2024 VS 2031
  • Figure 30. Asia Pacific Fibrinogen Sales Value, (2020-2031) & (US$ Million)
  • Figure 31. Asia Pacific Fibrinogen Sales Value by Region (%), 2024 VS 2031
  • Figure 32. South America Fibrinogen Sales Value, (2020-2031) & (US$ Million)
  • Figure 33. South America Fibrinogen Sales Value by Country (%), 2024 VS 2031
  • Figure 34. Middle East & Africa Fibrinogen Sales Value, (2020-2031) & (US$ Million)
  • Figure 35. Middle East & Africa Fibrinogen Sales Value by Country (%), 2024 VS 2031
  • Figure 36. Key Countries/Regions Fibrinogen Sales Value (%), (2020-2031)
  • Figure 37. Key Countries/Regions Fibrinogen Sales Volume (%), (2020-2031)
  • Figure 38. United States Fibrinogen Sales Value, (2020-2031) & (US$ Million)
  • Figure 39. United States Fibrinogen Sales Value by Type (%), 2024 VS 2031
  • Figure 40. United States Fibrinogen Sales Value by Application (%), 2024 VS 2031
  • Figure 41. Europe Fibrinogen Sales Value, (2020-2031) & (US$ Million)
  • Figure 42. Europe Fibrinogen Sales Value by Type (%), 2024 VS 2031
  • Figure 43. Europe Fibrinogen Sales Value by Application (%), 2024 VS 2031
  • Figure 44. China Fibrinogen Sales Value, (2020-2031) & (US$ Million)
  • Figure 45. China Fibrinogen Sales Value by Type (%), 2024 VS 2031
  • Figure 46. China Fibrinogen Sales Value by Application (%), 2024 VS 2031
  • Figure 47. Japan Fibrinogen Sales Value, (2020-2031) & (US$ Million)
  • Figure 48. Japan Fibrinogen Sales Value by Type (%), 2024 VS 2031
  • Figure 49. Japan Fibrinogen Sales Value by Application (%), 2024 VS 2031
  • Figure 50. South Korea Fibrinogen Sales Value, (2020-2031) & (US$ Million)
  • Figure 51. South Korea Fibrinogen Sales Value by Type (%), 2024 VS 2031
  • Figure 52. South Korea Fibrinogen Sales Value by Application (%), 2024 VS 2031
  • Figure 53. Southeast Asia Fibrinogen Sales Value, (2020-2031) & (US$ Million)
  • Figure 54. Southeast Asia Fibrinogen Sales Value by Type (%), 2024 VS 2031
  • Figure 55. Southeast Asia Fibrinogen Sales Value by Application (%), 2024 VS 2031
  • Figure 56. India Fibrinogen Sales Value, (2020-2031) & (US$ Million)
  • Figure 57. India Fibrinogen Sales Value by Type (%), 2024 VS 2031
  • Figure 58. India Fibrinogen Sales Value by Application (%), 2024 VS 2031
  • Figure 59. Fibrinogen Industrial Chain
  • Figure 60. Fibrinogen Manufacturing Cost Structure
  • Figure 61. Channels of Distribution (Direct Sales, and Distribution)
  • Figure 62. Bottom-up and Top-down Approaches for This Report
  • Figure 63. Data Triangulation
  • Figure 64. Key Executives Interviewed